Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Mallard

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Genome Medicine|May 29, 2015
Rapid determination of anti-tuberculosis drug resistance from whole-genome sequencesFrancesc Coll, Ruth McNerney, Mark D Preston, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 2016
Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measuresPascale Trepanier, Kim Mallard, Danièle Meunier, et al.
The Journal of Antimicrobial Chemotherapy|August 27, 2021
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled studySaye H Khoo, Richard Fitzgerald, Thomas Fletcher, et al.
Nature Communications|July 21, 2025
Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trialDean A Fennell, Kayleigh Hill, Min Zhang, et al.
Nature Genetics|April 21, 2018
Author Correction: Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosisFrancesc Coll, Jody Phelan, Grant A Hill-Cawthorne, et al.
Nature Genetics|January 24, 2018
Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosisFrancesc Coll, Jody Phelan, Grant A Hill-Cawthorne, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Genome Medicine|May 29, 2015
Rapid determination of anti-tuberculosis drug resistance from whole-genome sequencesFrancesc Coll, Ruth McNerney, Mark D Preston, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 2016
Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measuresPascale Trepanier, Kim Mallard, Danièle Meunier, et al.
The Journal of Antimicrobial Chemotherapy|August 27, 2021
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled studySaye H Khoo, Richard Fitzgerald, Thomas Fletcher, et al.
Nature Communications|July 21, 2025
Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trialDean A Fennell, Kayleigh Hill, Min Zhang, et al.
Nature Genetics|April 21, 2018
Author Correction: Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosisFrancesc Coll, Jody Phelan, Grant A Hill-Cawthorne, et al.
Nature Genetics|January 24, 2018
Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosisFrancesc Coll, Jody Phelan, Grant A Hill-Cawthorne, et al.
Pageof 3